Verona Pharma Plc (LON:VRP)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $50.27 and traded as low as $40.00. Verona Pharma shares last traded at $41.49, with a volume of 34,644 shares.

The company has a debt-to-equity ratio of 2.68, a current ratio of 4.07 and a quick ratio of 3.79. The company has a market cap of $43.71 million and a price-to-earnings ratio of -1.59. The business’s fifty day moving average price is GBX 45.09 and its 200 day moving average price is GBX 50.18.

About Verona Pharma (LON:VRP)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.

Recommended Story: Operating Income

Receive News & Ratings for Verona Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma and related companies with MarketBeat.com's FREE daily email newsletter.